Publicacións en colaboración con investigadores/as de Universidade da Coruña (8)

2024

  1. First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

    Breast Cancer Research and Treatment

2022

  1. Thirty-second sit-to-stand test as an alternative for estimating peak oxygen uptake and 6-min walking distance in women with breast cancer: a cross-sectional study

    Supportive Care in Cancer, Vol. 30, Núm. 10, pp. 8251-8260

2021

  1. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  2. Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study

    ESMO open, Vol. 6, Núm. 2, pp. 100090

2019

  1. Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)

    Scientific Reports

  2. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy

    Cells, Vol. 8, Núm. 12

  3. Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

2015

  1. Trombosis venosa de localización atípica en pacientes con cáncer

    Medicina Clinica, Vol. 144, Núm. S1, pp. 38-40